Future of Missouri's low-income utility assistance program uncertain after federal cuts
(Brian Brown iStock / Getty Images Plus).
Included in the massive federal workforce cuts at the Department of Health and Human Services this week was the elimination of an office that runs a program over 100,000 Missouri families rely on to help pay their heating and cooling bills.
The layoffs within the Low Income Home Energy Assistance Program, which provides Congressionally-approved funds that are administered by Missouri's social services department, leaves the program's future in limbo.
LIHEAP is designed to help those with few resources cover their home energy bills in the summer and winter. Since October, the program has helped offset utility costs for 100,839 households, according to a spokesperson for the Department of Social Services.
The state received over $136.4 million for the program in fiscal year 2023, and the average benefit for the heating and cooling program was around $675 per household.
The Department of Social Services has 'not received any official updates regarding potential program reductions,' said spokesperson Baylee Watts, and the federal government hasn't announced program cuts. But advocates fear that without the federal staff, the future allocation of funding is uncertain.
'Any cuts to LIHEAP will be detrimental to Missourians who are already struggling to keep up with increasing electric and gas bills,' said Sandra Padgett, executive director of Consumers Council of Missouri, in a press release.
States are still waiting for around 10% of their annual funding allocation for the federal fiscal year that began in October. That amount usually arrives in June. Watts said Missouri hasn't been notified yet of what that amount is, but it was $8.1 million last year.
Those funds aren't expected to be needed until the fiscal year that starts in October, though, Watts said, based on the way Missouri has allocated funding.
'At this moment, DSS does not anticipate any impact on services,' Watts said.
At the same time, a bill adding a charge onto utility bills passed the state legislature and is awaiting the governor's signature.
SUPPORT: YOU MAKE OUR WORK POSSIBLE
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
2 hours ago
- Boston Globe
House passes bill overhauling cannabis laws, Cannabis Control Commission
Advertisement Frustration with the slow pace of regulatory changes, headline-grabbing internal conflicts at the CCC, and a plea from the inspector general for the Legislature to intervene at the 'rudderless agency' combined last summer to get lawmakers thinking more seriously about a response. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up House Speaker Ronald Mariano recounted Wednesday how he went to Donahue last year to say 'we're going to have to fix this.' He said Treasurer Deborah Goldberg's removal of CCC chairwoman Shannon O'Brien had been dragged into court by that point, a long-running saga that has shined a light on internal strife at the CCC. That directive to Donahue led to a series of hearings and conversations that resulted in the bill before the House on Wednesday. 'He did the work. You could talk to him, and he could explain the process. It got us where we thought we had to take it away from the treasurer,' Mariano said before yielding to Donahue to give a more thorough explanation of the House's thinking around accountability at the CCC. Advertisement Today, the CCC is a five-commissioner independent body, with appointments made singularly and jointly by the governor, attorney general and treasurer, with the treasurer selecting the chair. Under the House-approved bill, the CCC would be consolidated entirely under the governor. The state's executive would appoint all three commissioners and select one of them to serve as chair (who would be the only full-time commissioner). The CCC would be 'subject to the laws applicable to agencies under the control of the governor.' Asked what makes the CCC's existing model unworkable, Mariano said it was a structural problem but gave a conflicted explanation. 'It was created by a ballot question that had no rhyme or reason to it ... there was no accountability,' he said. The speaker, who started his scrum with reporters by raising the subject of 'legislation by referendum' and the trend of advocates going around a slow-moving Legislature to make laws at the statewide ballot, added, 'We've been railing against government by referendum, and this is a perfect example why it doesn't work.' The CCC's existing structure is largely modeled on the Gaming Commission, where five full-time members with specific areas of expertise are appointed by the governor, treasurer and attorney general. But Mariano claimed Wednesday that 'the problem is they weren't written by the same people.' 'The gaming stuff was written by House people,' he said. 'The people in the marketplace wrote this bill, and they weren't interested in controlling it, in making sure there was accountability up and down the line. As a matter of fact, this was a rush to get into the market. Everyone thought they were going to get rich.' Advertisement The Mariano, who was majority leader at the time, was the lead House negotiator on the 2017 law that structured the CCC. The structure that was put in place 'This is legislation by referendum, and this is the problem, no one really focused on the writing of the ballot question on how this would be administered. And when it hit, the public had no idea what the problems were going to be and where they were going to be,' Mariano said Wednesday. Last summer, Inspector General Jeffrey Shapiro's office Advertisement Mariano was not available to clarify his comments Wednesday afternoon, but a spokesperson sent a statement saying his 'main point was that the Legislature was responding to a law that was passed by a referendum, which created a new industry outside of the typical legislative process, forcing the Legislature to address a number of unknowns.' 'In order to safely and effectively carry out the will of the voters, the Legislature has been forced to revise the original language multiple times. The legislation that the House is voting on today is better because of what we have learned since 2016, and establishes a new structure, different from the one that the ballot initiative spelled out,' Mariano spokesperson Ana Vivas said. The bill the House passed Wednesday also seeks to address intoxicating hemp-based products that largely fall into a gray area of the law and between the regulatory cracks by banning their sale without a license and setting up a new framework to regulate and tax them. Hemp beverages could only be sold by retailers licensed by the Alcoholic Beverages Control Commission to sell all alcohol and all hemp-based products would need to be registered with the CCC. 'This ban and accompanying regulatory structure will help provide guidance and clarity on hemp products, removing those which are unregulated, of unknown origin or composition, and too easily accessible to minors,' Donahue said Wednesday. The House bill adjusts the existing cap on retail licenses any one operator can hold. The current limit is three, and the House bill would raise the cap on retail licenses to six over a three-year period (increasing first to four, a year later to five and finally to six). Opponents of that idea have slammed it as a 'gift to corporate cannabis and a death sentence for local and social equity businesses.' The existing three-license caps would remain in place for cultivation and manufacturing. Advertisement On the medical side of the legal marijuana world, the bill eliminates the requirement that medical marijuana businesses be 'vertically integrated,' meaning they must grow and process all the marijuana they sell. Patients and advocates have been calling for that change for years, saying the medical-only options have become scarce across Massachusetts since cannabis was legalized for non-medical use.
Yahoo
3 hours ago
- Yahoo
State-level AI regulation ban emerging as D.C. flashpoint
BOSTON (SHNS) – Governors and legislatures 'won't be happy' if the federal government bars them from enacting any state-level regulations on artificial intelligence for the next decade, U.S. Sen. Ed Markey said Wednesday while pledging an effort to get the policy rider tossed from a funding bill. The junior senator from Massachusetts convened civil rights activists and academic experts for a virtual event, where they escalated their opposition to a provision in the U.S. House-approved reconciliation package imposing a 10-year moratorium on state AI restrictions. Markey said that when the bill emerges in the U.S. Senate, he will try to have it eliminated 'as a violation of the Senate rules for reconciliation.' 'We have to be clear about the provision: rather than proposing any plan to address the risks of AI, [the bill would] say you can't do anything about it. But governors are not going to be happy with that, state legislatures won't be happy with it, and I think increasingly, Republicans and Democrats are not going to be happy with it,' Markey said Wednesday. Alondra Nelson, a former Biden administration science official who is now a professor at Princeton University's Institute for Advanced Study, argued that governments cannot wait another decade before pursuing limitations on the use of AI and automated decision-making systems. 'AI systems are already, today, reshaping equality and opportunity in real people's lives. We know that IRS algorithms have disproportionately targeted black taxpayers for audits. We know that facial recognition systems are already leading to wrongful arrests. We know already that insurance companies are using surveillance data that creates discriminatory pricing for different Americans. We know that the uses of AI in health care are sometimes missing cancer in darker-skin patients while detecting it in other patients,' Nelson said. 'These aren't hypothetical future risks. They're certainly not risks that we can wait for 10 years to address. These are documented harms that are happening to members of the American public right now.' The U.S. House Energy and Commerce Committee added the moratorium language to the budget reconciliation bill. At a markup hearing last month, committee chair Rep. Brett Guthrie of Kentucky said the proposal would implement 'guardrails that protect against state-level AI laws that could jeopardize our technological leadership.' However, the proposal has drawn some bipartisan pushback. Republican Rep. Marjorie Taylor Greene of Georgia said Tuesday she did not know the 10-year AI regulation ban was in the bill when she voted to advance it and is 'adamantly OPPOSED to this.' She added that she would not vote in favor of the finalized bill — which cleared the House by a one-vote margin — if it returns from the Senate still containing the moratorium. Forty attorneys general, both Democrats and Republicans, jointly penned a letter to congressional leaders on May 16 announcing opposition to the provision, warning that its impact 'would be sweeping and wholly destructive of reasonable state efforts to prevent known harms associated with AI.' Attorneys general previously called for federal AI governance to focus on 'high risk' systems with emphasis on transparency, testing and enforcement. Attorney general letter on AI moratoriumDownload 'Rather than follow the recommendation from the bipartisan coalition of State Attorneys General, the amendment added to the reconciliation bill abdicates federal leadership and mandates that all states abandon their leadership in this area as well,' the 40 AGs wrote in the letter circulated by the National Association of Attorneys General. 'This bill does not propose any regulatory scheme to replace or supplement the laws enacted or currently under consideration by the states, leaving Americans entirely unprotected from the potential harms of AI. Moreover, this bill purports to wipe away any state-level frameworks already in place.' Massachusetts Attorney General Andrea Campbell was among the letter's signatories. On Beacon Hill, elected officials have been weighing the potential risks of AI against the economic upsides of a fast-growing industry. Lawmakers and Gov. Maura Healey last year included $100 million in an economic development bond bill to create a Massachusetts AI Hub, which Healey's office said would 'facilitate the application of artificial intelligence across the state's ecosystem.' Lawmakers targeted AI in several bills pending this term, proposing new guardrails around its use in health care decision-making, additional consumer protection measures, a study on greenhouse gas emissions from the electrically demanding technology, and more. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Indianapolis Star
4 hours ago
- Indianapolis Star
Telomir Pharmaceuticals Announces Telomir-1 Resets the Body's Epigenetic Clock, Reverses DNA Methylation, and Restores Youthful Gene Regulation in an Ultra-Rare Accelerated Aging Animal Model of Werner Syndrome
Treatment restored gene control, extended telomere length beyond healthy levels, reversed muscle and weight loss, reduced oxidative stress, and resulted in 100% survival – highlighting Telomir-1's potential to reverse key hallmarks of aging MIAMI, FL / ACCESS Newswire Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the 'Company,' an emerging leader in age-reversal science, today announced compelling new preclinical data demonstrating that its lead candidate, Telomir-1, administered orally, significantly increases telomere length, reverses body weight and muscle loss, and resets cellular aging markers in a validated animal model of Werner Syndrome (WS) -a rare genetic disorder also known as adult-onset progeria. These findings confirm and build upon the Company's previously reported results from a preclinical C. elegans study, which demonstrated that Telomir-1 restored lifespan and normalized physiological decline in animals with a wrn gene mutation. Werner Syndrome: A Rare and Devastating Accelerated Aging Disorder Werner Syndrome is a rare autosomal recessive disorder caused by mutations in the wrn gene, which plays a critical role in DNA repair and telomere maintenance. Patients typically begin showing signs of premature aging-such as graying hair, cataracts, diabetes, osteoporosis, and atherosclerosis-in their 20s or 30s. Median life expectancy is 40-50 years. There are currently no FDA-approved treatments. To model this disease, the Company's study utilized the Sen57wrn-/-ND6-/+ zebrafish model, which replicates key features of Werner Syndrome, including telomere loss, mitochondrial dysfunction, retinal degeneration, muscle deterioration, and abnormal DNA methylation. Key Preclinical Findings 1. DNA Methylation Reversal – Resetting the Genetic Clock DNA methylation is one of the body's key mechanisms for controlling which genes are turned on or off. It works by attaching small chemical tags (called methyl groups) to DNA at locations known as CpG islands -which act like gene 'on/off' switches. When methylation patterns are intact, cells know which genes to express and when. However, with aging and disease, this regulatory system starts to break down – a phenomenon known as epigenetic drift. In these cases, genes that should be off may turn on inappropriately, and protective genes may be silenced. This malfunction in gene regulation is strongly linked to a wide range of chronic diseases including: Cancer (via silencing of tumor suppressor genes) Neurodegenerative diseases like Alzheimer's and Parkinson's Autoimmune diseases such as lupus and multiple sclerosis Metabolic conditions like Type 2 diabetes Premature aging disorders like progeria and Werner Syndrome In this study, Telomir-1 reversed age-related hypomethylation at two chromosomal regions, restoring methylation patterns to above-normal wild-type levels. This suggests that Telomir-1 may help restore healthy gene regulation and reset the body's epigenetic aging clock, reducing the risk of dysfunction in key biological systems. 2. Telomere Elongation – Rebuilding the Chromosomal Clock Telomeres are the protective caps at the ends of chromosomes that shorten with each cell division and under stress. Telomere shortening is considered one of the hallmarks of aging. In the study, compared with the shortened length in the mutated animals, Telomir-1 increased telomere length by about three-fold. At the higher dose, telomere length significantly exceeded wild-type (healthy) levels, suggesting not only restoration but also potential enhancement of chromosomal integrity 3. Muscle Mass and Body Weight Recovery In the wrn-mutant zebrafish model, animals exhibited a 50-60% reduction in body weight and muscle volume. After 14 days of Telomir-1 treatment, these physical markers were restored to levels statistically indistinguishable from healthy controls – indicating functional recovery and metabolic improvement. 4. Oxidative Stress Reduction Reactive oxygen species (ROS), which damage cells and accelerate aging, were elevated in untreated animals. Telomir-1 reduced ROS levels by up to 50%, suggesting improved cellular resilience. 5. Survival Benefit Roughly 15% of untreated animals died during the 14-day study period, whereas no deaths occurred in any Telomir-1 treated groups – highlighting a systemic survival advantage. 'These results reinforce my conviction that Telomir-1 may represent one of the most important scientific developments in the field of aging,' said Erez Aminov, Chairman and CEO of Telomir. 'While we remain in the preclinical phase, the consistency and strength of the data demand serious attention. My full commitment is behind advancing Telomir-1 toward human studies in the most responsible and rigorous way. The potential here is too significant to ignore.' 'This is one of the most comprehensive rejuvenation profiles we've seen in a vertebrate aging model,' added Dr. Itzchak Angel, Chief Scientific Advisor. 'The ability to reverse both genomic and epigenetic instability while improving survival supports the growing potential of Telomir-1 as a foundational therapy for aging-related diseases.' Cautionary Note Regarding Forward-Looking Statements This press release, statements of Telomir's management or advisors related thereto, and the statements contained in the news story linked in this release contain 'forward-looking statements,' which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These risks and uncertainties include, but are not limited to, the potential use of the data from our studies, our ability to develop and commercialize Telomir-1 for specific indications, and the safety of Telomir-1. Any forward-looking statements in this press release are based on Telomir's current expectations, estimates and projections only as of the date of this release. These risks and uncertainties include, but are not limited to, the potential use of the data from our studies, our ability to develop and commercialize Telomir-1 for specific indications and safety of Telomir-1. These and other risks concerning Telomir's programs and operations are described in additional detail in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which is on file with the SEC. Telomir explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law. Contact Information SOURCE: Telomir Pharmaceuticals, Inc View the original press release on ACCESS Newswire
